OBJECTIVE: To optimise sample preparation of synovial fluid for Chlamydia trachomatis (CT) specific polymerase chain reaction (PCR). METHODS: Serial dilutions of purified CT elementary bodies in synovial fluid were prepared. The synovial fluid pellet was processed by eight different methods of sample preparation. Then samples were analysed by CT specific PCR. The sensitivity of PCR was the basis of ranking of the eight different methods. RESULTS: Highest sensitivity was achieved by methods including an additional step of DNA isolation. Additional extraction of protein and polysaccharides by cetyltrimethylammonium bromide (CTAB) increased sensitivity. Addition of hyaluronidase did not increase sensitivity of QIAEX-DNA extraction but was necessary, however, before phenol-chloroform-DNA extraction. CONCLUSIONS: The method of synovial fluid sample preparation significantly influences the sensitivity of subsequent PCR. Additional DNA isolation and extraction of PCR inhibitors by CTAB led to higher sensitivity.
OBJECTIVE: To optimise sample preparation of synovial fluid for Chlamydia trachomatis (CT) specific polymerase chain reaction (PCR). METHODS: Serial dilutions of purified CT elementary bodies in synovial fluid were prepared. The synovial fluid pellet was processed by eight different methods of sample preparation. Then samples were analysed by CT specific PCR. The sensitivity of PCR was the basis of ranking of the eight different methods. RESULTS: Highest sensitivity was achieved by methods including an additional step of DNA isolation. Additional extraction of protein and polysaccharides by cetyltrimethylammonium bromide (CTAB) increased sensitivity. Addition of hyaluronidase did not increase sensitivity of QIAEX-DNA extraction but was necessary, however, before phenol-chloroform-DNA extraction. CONCLUSIONS: The method of synovial fluid sample preparation significantly influences the sensitivity of subsequent PCR. Additional DNA isolation and extraction of PCR inhibitors by CTAB led to higher sensitivity.
Authors: L Koehler; E Nettelnbreker; A P Hudson; N Ott; H C Gérard; P J Branigan; H R Schumacher; W Drommer; H Zeidler Journal: Microb Pathog Date: 1997-03 Impact factor: 3.738
Authors: J Freise; H C Gérard; T Bunke; J A Whittum-Hudson; H Zeidler; L Köhler; A P Hudson; J G Kuipers Journal: Ann Rheum Dis Date: 2001-02 Impact factor: 19.103
Authors: C Fendler; S Laitko; H Sörensen; C Gripenberg-Lerche; A Groh; J Uksila; K Granfors; J Braun; J Sieper Journal: Ann Rheum Dis Date: 2001-04 Impact factor: 19.103
Authors: Michael C Jendro; Elke Raum; Sebastian Schnarr; Lars Köhler; Henning Zeidler; Jens G Kuipers; Michael Martin Journal: Rheumatol Int Date: 2003-10-31 Impact factor: 2.631
Authors: J G Kuipers; J Sibilia; S Bas; H Gaston; K Granfors; T L Vischer; N Hajjaj-Hassouni; A Ladjouze-Rezig; S Sellami; J Wollenhaupt; H Zeidler; H R Schumacher; M Dougados Journal: Clin Rheumatol Date: 2008-08-08 Impact factor: 2.980
Authors: T K Kvien; J S H Gaston; T Bardin; I Butrimiene; B A C Dijkmans; M Leirisalo-Repo; P Solakov; M Altwegg; P Mowinckel; P-A Plan; T Vischer Journal: Ann Rheum Dis Date: 2004-09 Impact factor: 19.103
Authors: María G Lacoste; Héctor Tamashiro; Silvia G Correa; Ana M S de Guzmán; María S Di Genaro Journal: Rheumatol Int Date: 2006-12-02 Impact factor: 3.580